Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

CUSIP: 92539P101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
89,600,000
Total 13F shares
37,677,821
Share change
+37,677,821
Total reported value
$2,254,528,000
Price per share
$60.25
Number of holders
69
Value change
+$2,254,527,999
Number of buys
69

Quarterly Holders Quick Answers

What is CUSIP 92539P101?
CUSIP 92539P101 identifies VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q2 2021

As of 30 Jun 2021, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,677,821 shares. The largest 10 holders included Alphabet Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Casdin Capital, LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, Rock Springs Capital Management LP, JPMORGAN CHASE & CO, and RA CAPITAL MANAGEMENT, L.P.. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.